Hemogenyx Pharmaceuticals Plc HOPHF OTC

Other OTC • Healthcare • Biotechnology • GB • USD

SharesGrow Score

11/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Hemogenyx Pharmaceuticals Plc (HOPHF) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 10/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

11/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

28/100

→ Income

✗

GROWTH

15/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — HOPHF

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-2.13

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2015	$-0.01	$6.85K	$-180.88K	-2642.5%
2016	$-1.30	$0.00	$-519.9K	-
2017	$-3.63	$0.00	$-2.36M	-
2018	$-1.72	$0.00	$-1.48M	-
2019	$-1.61	$0.00	$-1.45M	-
2020	$-2.01	$0.00	$-2.08M	-
2021	$-2.64	$0.00	$-5.1M	-
2022	$-1.62	$0.00	$-3.98M	-
2023	$-2.37	$0.00	$-6.69K	-
2024	$-2.13	$0.00	$-5.62M	-